Showing results (101-110 of 190) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|June 3, 2025
A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancerKimberley T Lee, Bihe Hu, Dinorah Martinez Tyson, et al.Frontiers in Genetics|July 2, 2021
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast CancerDaniel L Hertz, Karen Lisa Smith, Yuhua Zong, et al.Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.Current Oncology (Toronto, Ont.)|February 13, 2021
Integrative Oncology Education: An Emerging Competency for Oncology ProvidersSafiya Karim, Rita Benn, Linda E Carlson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2011
Cytoplasmic estrogen receptor in breast cancerAllison W Welsh, Donald R Lannin, Gregory S Young, et al.Molecular Oncology|August 16, 2015
Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analysesDaniel L Hertz, Kelley M Kidwell, Jacklyn N Thibert, et al.Breast Cancer Research and Treatment|June 24, 2017
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patientsDaniel L Hertz, Kelly A Speth, Kelley M Kidwell, et al.Cell Reports. Medicine|March 8, 2025
A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigueCaleb Mayer, Olivia Walch, Walter Dempsey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.Pageof 19